INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

ATHEALTERITY THERAPEUTICS LTD

CIK 0001131343

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells3 / 0
Max Insider Score56
Connections5with evidence

ATHE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
56
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Stamler David AllenDirector, Chief Executive Officer · Sep 8, 2026
  • ← Insider ofevidence
    Marks Peter AshleyDirector · Sep 8, 2026
  • ← Insider ofevidence
    Babarczy Julian MichaelDirector · Jun 23, 2026
52
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY
$24K
47.6K sh
Aug 31, 2026
Sep 8, 2026
traded Aug 31, 2026
+8d
SEC FORM 4

Evidence

56
SA
Stamler David AllenDirector, Chief Executive Officer
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC FORM 4

Evidence

19
BM
Babarczy Julian MichaelDirector
ATHEALTERITY THERAPEUTICS LTD
Grant or award
A—
2.00M sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC FORM 4

Evidence

19
GB
Gozlan Lawrence BernardDirector
ATHEALTERITY THERAPEUTICS LTD
Grant or award
A—
1.00M sh
Jun 15, 2026Jun 23, 2026
traded Jun 15, 2026
+8dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Gozlan Lawrence BernardDirector · Jun 23, 2026